When a Michigan woman was told to raise $10,000 for a heart transplant, outrage spread on social media. But experts say “wallet biopsies” are common

Quick Read

Shereese Hickson’s multiple sclerosis was flaring again. Spasms in her legs and other symptoms were getting worse. She could still walk and take care of her son six years after doctors diagnosed the disease, which attacks the central nervous system

Quick Read

Money is just the obvious obstacle. A few diseases, like H.I.V., so far have outwitted both the immune system and scientists

Quick Read

Two years into Maribel’s recovery and treatment, David’s boss gathered his staff into his office. Don’t worry, he said, business is good. Your jobs are safe. But there would be one change: Health insurance offered through the company would soon be discontinued. It had simply become too expensive

Quick Read

The nation’s hospitals have been merging at a rapid pace for a decade, forming powerful organizations that influence nearly every health care decision consumers make. The hospitals have argued that consolidation benefits consumers with cheaper prices from coordinated services and other savings

Quick Read

Two decades ago, the costs began rising well beyond that of other nations, and in recent years have shot up again. What can explain it?

Quick Read

On Mother’s Day, Nicole Smith-Holt, whose son died last year after rationing his insulin, protested insulin prices at a rally at the Minnesota state capitol. That same month, she traveled to Indianapolis to meet with a representative of the insulin maker Eli Lilly

Quick Read

A tragic snapshot of the opioid crisis. The pricing and availability of drugs — legal and illegal — illuminate how markets chase profits and reward innovation

Quick Read